Data:
{
"symbol": "CELC",
"price": 91.155,
"marketCap": 4445290983,
"beta": 0.164,
"lastDividend": 0,
"range": "13.59-151.02",
"change": -0.535,
"changePercentage": -0.58349,
"volume": 270700,
"averageVolume": 1577825,
"companyName": "Celcuity Inc.",
"currency": "USD",
"cik": "0001603454",
"isin": "US15102K1007",
"cusip": "15102K100",
"exchangeFullName": "NASDAQ",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://www.celcuity.com",
"description": "Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.",
"ceo": "Brian F. Sullivan",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "155",
"phone": "763 392 0767",
"address": "2800 Campus Drive",
"city": "Minneapolis",
"state": "MN",
"zip": "55446",
"image": "https://images.financialmodelingprep.com/symbol/CELC.png",
"ipoDate": "2017-09-19",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false,
"sec_filings": [
{
"form": "SCHEDULE 13G",
"date": "2026-07-16",
"accession": "0001104659-26-084329",
"description": "",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000110465926084329/xslSCHEDULE_13G_X02/primary_doc.xml"
},
{
"form": "SCHEDULE 13D/A",
"date": "2026-07-16",
"accession": "0001104659-26-084327",
"description": "",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000110465926084327/xslSCHEDULE_13D_X02/primary_doc.xml"
},
{
"form": "4",
"date": "2026-07-16",
"accession": "0001193125-26-306299",
"description": "4",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000119312526306299/xslF345X06/ownership.xml"
},
{
"form": "8-K/A",
"date": "2026-07-15",
"accession": "0001493152-26-033357",
"description": "8-K/A",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000149315226033357/form8-ka.htm"
},
{
"form": "8-K",
"date": "2026-07-15",
"accession": "0001493152-26-033223",
"description": "8-K",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000149315226033223/form8-k.htm"
},
{
"form": "144",
"date": "2026-07-14",
"accession": "0001104659-26-083659",
"description": "",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000110465926083659/xsl144X01/primary_doc.xml"
},
{
"form": "144",
"date": "2026-07-14",
"accession": "0001104659-26-083657",
"description": "",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000110465926083657/xsl144X01/primary_doc.xml"
},
{
"form": "4",
"date": "2026-06-12",
"accession": "0001829248-26-000004",
"description": "",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000182924826000004/xslF345X06/form4-06122026_080606.xml"
},
{
"form": "4",
"date": "2026-06-12",
"accession": "0001688319-26-000010",
"description": "",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000168831926000010/xslF345X06/form4-06122026_080636.xml"
},
{
"form": "4",
"date": "2026-06-09",
"accession": "0001829248-26-000002",
"description": "",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000182924826000002/xslF345X06/form4-06092026_100617.xml"
},
{
"form": "4",
"date": "2026-06-09",
"accession": "0001296457-26-000008",
"description": "",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000129645726000008/xslF345X06/form4-06092026_100607.xml"
},
{
"form": "4",
"date": "2026-06-09",
"accession": "0001809717-26-000008",
"description": "",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000180971726000008/xslF345X06/form4-06092026_100642.xml"
},
{
"form": "4",
"date": "2026-06-09",
"accession": "0001213869-26-000007",
"description": "",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000121386926000007/xslF345X06/form4-06092026_100615.xml"
},
{
"form": "4",
"date": "2026-06-09",
"accession": "0001775749-26-000002",
"description": "",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000177574926000002/xslF345X06/form4-06092026_100638.xml"
},
{
"form": "4",
"date": "2026-06-09",
"accession": "0001688319-26-000008",
"description": "",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000168831926000008/xslF345X06/form4-06092026_100610.xml"
}
]
}
Data:
{
"symbol": "CELC",
"name": "Celcuity Inc.",
"price": 90.14,
"changePercentage": -1.69048,
"change": -1.55,
"volume": 752369,
"dayLow": 89.24,
"dayHigh": 92.66,
"yearHigh": 151.02,
"yearLow": 13.59,
"marketCap": 4395793200,
"priceAvg50": 106.8862,
"priceAvg200": 102.45765,
"exchange": "NASDAQ",
"open": 91.05,
"previousClose": 91.69,
"timestamp": 1784750401
}
Data:
{
"volume": 752369,
"avgVolume": 1577825,
"short_ratio": [
{
"symbol": "CELC",
"file_date": "2026-07-22",
"date": "20260722",
"short_volume": 161571,
"short_exempt_volume": 0,
"total_volume": 288180,
"short_volume_ratio": 0.5607,
"signal": "Bearish"
}
]
}
Data:
{
"symbol": "CELC",
"marketCap": 4395793200,
"enterpriseValueTTM": 4446181200,
"evToSalesTTM": 0,
"evToOperatingCashFlowTTM": -25.776158894325537,
"evToFreeCashFlowTTM": -25.710872607413403,
"evToEBITDATTM": -25.751227564158256,
"netDebtToEBITDATTM": -0.29183535176272307,
"currentRatioTTM": 12.313058926259371,
"incomeQualityTTM": 0.8942691538006906,
"grahamNumberTTM": null,
"grahamNetNetTTM": -3.8824279885880326,
"taxBurdenTTM": 1,
"interestBurdenTTM": 1.1160059246916152,
"workingCapitalTTM": 375718000,
"investedCapitalTTM": 376350000,
"returnOnAssetsTTM": -0.4702655523156591,
"operatingReturnOnAssetsTTM": -0.4255989926111128,
"returnOnTangibleAssetsTTM": -0.4702655523156591,
"returnOnEquityTTM": -2.4461000957459627,
"returnOnInvestedCapitalTTM": -0.49491466073863427,
"returnOnCapitalEmployedTTM": -0.494931728889278,
"earningsYieldTTM": -0.03929008611461943,
"freeCashFlowYieldTTM": -0.03933988523390955,
"capexToOperatingCashFlowTTM": -0.0025392481970178326,
"capexToDepreciationTTM": 2.4745762711864407,
"capexToRevenueTTM": 0,
"salesGeneralAndAdministrativeToRevenueTTM": 0,
"researchAndDevelopementToRevenueTTM": 0,
"stockBasedCompensationToRevenueTTM": 0,
"intangiblesToTotalAssetsTTM": 0,
"averageReceivablesTTM": 0,
"averagePayablesTTM": 8430500,
"averageInventoryTTM": 0,
"daysOfSalesOutstandingTTM": 0,
"daysOfPayablesOutstandingTTM": 81185.31914893616,
"daysOfInventoryOutstandingTTM": 0,
"operatingCycleTTM": 0,
"cashConversionCycleTTM": -81185.31914893616,
"freeCashFlowToEquityTTM": 49783000,
"freeCashFlowToFirmTTM": -140142000,
"tangibleAssetValueTTM": 53525000,
"netCurrentAssetValueTTM": 52290000,
"grossProfitMarginTTM": 0,
"ebitMarginTTM": 0,
"ebitdaMarginTTM": 0,
"operatingProfitMarginTTM": 0,
"pretaxProfitMarginTTM": 0,
"continuousOperationsProfitMarginTTM": 0,
"netProfitMarginTTM": 0,
"bottomLineProfitMarginTTM": 0,
"receivablesTurnoverTTM": 0,
"payablesTurnoverTTM": 0.00449588674191697,
"inventoryTurnoverTTM": 0,
"fixedAssetTurnoverTTM": 0,
"assetTurnoverTTM": 0,
"quickRatioTTM": 12.313058926259371,
"solvencyRatioTTM": -0.5403475222844389,
"cashRatioTTM": 4.371774412092379,
"priceToEarningsRatioTTM": -23.17223650385604,
"priceToEarningsGrowthRatioTTM": 0.9635847201230212,
"forwardPriceToEarningsGrowthRatioTTM": 0.263051323123032,
"priceToBookRatioTTM": 91.7193673169547,
"priceToSalesRatioTTM": 0,
"priceToFreeCashFlowRatioTTM": -25.419494593187995,
"priceToOperatingCashFlowRatioTTM": -28.460909118335923,
"debtToAssetsRatioTTM": 0.4768312187320194,
"debtToEquityRatioTTM": 3.6539747781410554,
"debtToCapitalRatioTTM": 0.7851299055816044,
"longTermDebtToCapitalRatioTTM": 0.7851186915625213,
"financialLeverageRatioTTM": 7.663035964502569,
"workingCapitalTurnoverRatioTTM": 0,
"operatingCashFlowRatioTTM": -5.193821324260035,
"operatingCashFlowSalesRatioTTM": 0,
"freeCashFlowOperatingCashFlowRatioTTM": 1.002539248197018,
"debtServiceCoverageRatioTTM": -5.2580625513902,
"interestCoverageRatioTTM": -5.683828905678771,
"shortTermOperatingCashFlowCoverageRatioTTM": -13268.615384615385,
"operatingCashFlowCoverageRatioTTM": -0.8819556291830922,
"capitalExpenditureCoverageRatioTTM": -393.8173515981735,
"dividendPaidAndCapexCoverageRatioTTM": -393.8173515981735,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 0,
"netIncomePerShareTTM": -3.541608362371795,
"interestDebtPerShareTTM": 4.193741250224511,
"cashPerShareTTM": 2.665873416116894,
"bookValuePerShareTTM": 0.9827804381652909,
"tangibleBookValuePerShareTTM": 0.9827804381652909,
"shareholdersEquityPerShareTTM": 0.9827804381652909,
"operatingCashFlowPerShareTTM": -3.1671511133116743,
"capexPerShareTTM": 0.00804218275415969,
"freeCashFlowPerShareTTM": -3.175193296065834,
"netIncomePerEBTTTM": 1,
"ebtPerEbitTTM": 1.033875411382567,
"priceToFairValueTTM": 91.7193673169547,
"debtToMarketCapTTM": 0.044492311421747505,
"effectiveTaxRateTTM": 0,
"enterpriseValueMultipleTTM": -25.751227564158256,
"dividendPerShareTTM": 0,
"revenue_history": [],
"dcf": {
"symbol": "CELC",
"date": "2026-07-22",
"dcf": -0.680453272745863,
"Stock Price": 90.67
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "CELC",
"reportedCurrency": "USD",
"cik": "0001603454",
"filingDate": "2026-03-26",
"acceptedDate": "2026-03-26 07:30:43",
"fiscalYear": "2025",
"period": "FY",
"revenue": 0,
"costOfRevenue": 167000,
"grossProfit": -167000,
"researchAndDevelopmentExpenses": 144995000,
"generalAndAdministrativeExpenses": 27197000,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 27197000,
"otherExpenses": 0,
"operatingExpenses": 172192000,
"costAndExpenses": 172192000,
"netInterestIncome": -4850000,
"interestIncome": 12298000,
"interestExpense": 17148000,
"depreciationAndAmortization": 167000,
"ebitda": -159727000,
"ebit": -159894000,
"nonOperatingIncomeExcludingInterest": -12298000,
"operatingIncome": -172192000,
"totalOtherIncomeExpensesNet": -4850000,
"incomeBeforeTax": -177042000,
"incomeTaxExpense": 0,
"netIncomeFromContinuingOperations": -177042000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": -177042000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": -177042000,
"eps": -3.78,
"epsDiluted": -3.78,
"weightedAverageShsOut": 52539744,
"weightedAverageShsOutDil": 52539744
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "CELC",
"reportedCurrency": "USD",
"cik": "0001603454",
"filingDate": "2026-03-26",
"acceptedDate": "2026-03-26 07:30:43",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 165703000,
"shortTermInvestments": 275794000,
"cashAndShortTermInvestments": 441497000,
"netReceivables": 0,
"accountsReceivables": 0,
"otherReceivables": 0,
"inventory": 0,
"prepaids": 0,
"otherCurrentAssets": 24162000,
"totalCurrentAssets": 465659000,
"propertyPlantEquipmentNet": 550000,
"goodwill": 0,
"intangibleAssets": 0,
"goodwillAndIntangibleAssets": 0,
"longTermInvestments": 0,
"taxAssets": 0,
"otherNonCurrentAssets": 349000,
"totalNonCurrentAssets": 899000,
"otherAssets": 0,
"totalAssets": 466558000,
"totalPayables": 6407000,
"accountPayables": 6407000,
"otherPayables": 0,
"accruedExpenses": 0,
"shortTermDebt": 54000,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 0,
"otherCurrentLiabilities": 37691000,
"totalCurrentLiabilities": 44152000,
"longTermDebt": 195324000,
"capitalLeaseObligationsNonCurrent": 0,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 126527000,
"totalNonCurrentLiabilities": 321851000,
"otherLiabilities": 0,
"capitalLeaseObligations": 0,
"totalLiabilities": 366003000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 48000,
"retainedEarnings": -448897000,
"additionalPaidInCapital": 549404000,
"accumulatedOtherComprehensiveIncomeLoss": 0,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 100555000,
"totalEquity": 100555000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 466558000,
"totalInvestments": 275794000,
"totalDebt": 195378000,
"netDebt": 29675000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "CELC",
"reportedCurrency": "USD",
"cik": "0001603454",
"filingDate": "2026-03-26",
"acceptedDate": "2026-03-26 07:30:43",
"fiscalYear": "2025",
"period": "FY",
"netIncome": -177042000,
"depreciationAndAmortization": 167000,
"deferredIncomeTax": 0,
"stockBasedCompensation": 21383000,
"changeInWorkingCapital": -2652000,
"accountsReceivables": 0,
"inventory": 0,
"accountsPayables": -3040000,
"otherWorkingCapital": 388000,
"otherNonCashItems": 4864000,
"netCashProvidedByOperatingActivities": -153280000,
"investmentsInPropertyPlantAndEquipment": -249000,
"acquisitionsNet": 0,
"purchasesOfInvestments": -396342000,
"salesMaturitiesOfInvestments": 332507000,
"otherInvestingActivities": 0,
"netCashProvidedByInvestingActivities": -64084000,
"netDebtIssuance": 222749000,
"longTermNetDebtIssuance": 222749000,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": 137849000,
"netCommonStockIssuance": 137849000,
"commonStockIssuance": 137849000,
"commonStockRepurchased": 0,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -46000,
"netCashProvidedByFinancingActivities": 360552000,
"effectOfForexChangesOnCash": 177,
"netChangeInCash": 143188177,
"cashAtEndOfPeriod": 165703000,
"cashAtBeginningOfPeriod": 22515000,
"operatingCashFlow": -153280000,
"capitalExpenditure": -249000,
"freeCashFlow": -153529000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 90.14,
"rsi": 40.863011525418095,
"sma20": 100.94850000000001,
"sma50": 106.88620000000003,
"sma200": 102.45775000000003,
"adx": 21.102885227068672,
"atr": 7.88,
"atr_pct": 8.74,
"high_52w": 144.98,
"low_52w": 5.35,
"structure": {
"ema8": 93.80299716075305,
"ema21": 98.3789056280493,
"ema50": 104.0207807137454,
"ema200": 96.01957057554425,
"checks": {
"price_above_all": false,
"ema_stacked": false,
"ema21_rising": false,
"ema50_rising": false,
"adx_over_30": false,
"higher_highs_lows": false,
"near_21ema": false
},
"dist_21ema_pct": -8.4,
"macd": {
"macd": -3.648,
"signal": -2.197,
"histogram": -1.451
},
"bollinger": {
"mid": 100.95,
"upper": 118.58,
"lower": 83.32,
"width_pct": 34.93
},
"crossover": {
"fresh_cross": false,
"pre_compressed": false,
"held_above_21": false,
"candles_since": 13,
"intraday_support": false
},
"momentum": {
"roc10": -17.2,
"checks": {
"roc_over_5": false,
"rsi_in_band": false,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": false,
"near_high": false
},
"volume": {
"rvol": 0.42,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": false,
"obv_new_high": false,
"surge_day": true,
"pullback_declining_vol": false,
"last_up_beats_down": true
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": -2.55,
"checks": {
"beats_spy_all": false,
"beats_sector_10d": false,
"rs_line_at_high": false,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"avg_vol_over_2m": false,
"mcap_over_1b": true,
"no_earnings_7d": true,
"not_lev_etf_spac": true,
"bidask_spread": null,
"dollar_vol_over_10m": true
},
"avg_dollar_vol": 143826637.875,
"avg_vol": 1577825
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": true,
"iv_contracting": true,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 0.1,
"iv_rank": 5.0
}
}
}
}
Data:
{
"prior_day": {
"high": 92.66,
"low": 89.24,
"close": 90.14,
"date": "2026-07-22"
},
"woodie_pivots": {
"PP": 90.54,
"R1": 91.85,
"S1": 88.43,
"R2": 93.96,
"S2": 87.12
},
"swing": {
"high_20d": 117.21,
"low_20d": 84.98,
"high_60d": 151.02,
"low_60d": 82.55
},
"orb": {
"high": 91.49,
"low": 89.93,
"date": "2026-07-22"
},
"vwap": 90.9,
"volume_profile": {
"poc": 90.68,
"vah": 104.51,
"val": 85.19,
"sessions": 20
},
"recent_daily": [
{
"d": "2026-06-16",
"o": 88.54,
"h": 89.505,
"l": 86.91,
"c": 87.32,
"v": 906054.656341
},
{
"d": "2026-06-17",
"o": 88.07,
"h": 88.85,
"l": 85.5934,
"c": 88.05,
"v": 1212278.353637
},
{
"d": "2026-06-18",
"o": 88.17,
"h": 89.4,
"l": 82.5536,
"c": 87.76,
"v": 2126823.411913
},
{
"d": "2026-06-22",
"o": 88.56,
"h": 91.265,
"l": 87.01,
"c": 89.93,
"v": 884643.612345
},
{
"d": "2026-06-23",
"o": 88.84,
"h": 92.605,
"l": 87.88,
"c": 90.21,
"v": 659112.915046
},
{
"d": "2026-06-24",
"o": 89.64,
"h": 96.9,
"l": 89.64,
"c": 96.38,
"v": 1042301.925679
},
{
"d": "2026-06-25",
"o": 95.42,
"h": 101.29,
"l": 95,
"c": 95.93,
"v": 1446315.080319
},
{
"d": "2026-06-26",
"o": 96.23,
"h": 101.24,
"l": 95,
"c": 99.95,
"v": 2565086.870249
},
{
"d": "2026-06-29",
"o": 100,
"h": 103.3131,
"l": 98.54,
"c": 102.52,
"v": 1032384.672928
},
{
"d": "2026-06-30",
"o": 103.63,
"h": 105.52,
"l": 101.185,
"c": 104.62,
"v": 1088291.449988
},
{
"d": "2026-07-01",
"o": 105.78,
"h": 106.92,
"l": 102.795,
"c": 104.49,
"v": 1098150.185287
},
{
"d": "2026-07-02",
"o": 105.84,
"h": 108.32,
"l": 102.62,
"c": 107.95,
"v": 1044326.574797
},
{
"d": "2026-07-06",
"o": 107.91,
"h": 111.04,
"l": 106.2,
"c": 108.58,
"v": 1137705.141171
},
{
"d": "2026-07-07",
"o": 110.44,
"h": 117.21,
"l": 108.93,
"c": 115.72,
"v": 1438266.532104
},
{
"d": "2026-07-08",
"o": 113.98,
"h": 116.41,
"l": 108.4175,
"c": 108.9,
"v": 1516708.947935
},
{
"d": "2026-07-09",
"o": 108.28,
"h": 113.74,
"l": 108.28,
"c": 113.51,
"v": 984054.921332
},
{
"d": "2026-07-10",
"o": 113.5,
"h": 113.5,
"l": 107.2501,
"c": 107.58,
"v": 698699.971707
},
{
"d": "2026-07-13",
"o": 106.7,
"h": 108.78,
"l": 100.625,
"c": 103.79,
"v": 1257573.759817
},
{
"d": "2026-07-14",
"o": 103.79,
"h": 113.73,
"l": 101.09,
"c": 111.05,
"v": 2150348.935572
},
{
"d": "2026-07-15",
"o": 94.81,
"h": 98,
"l": 85,
"c": 91.51,
"v": 8750375.690153
},
{
"d": "2026-07-16",
"o": 91.69,
"h": 91.69,
"l": 84.985,
"c": 88.29,
"v": 3416798.292461
},
{
"d": "2026-07-17",
"o": 86.13,
"h": 91.235,
"l": 86.07,
"c": 88.38,
"v": 1310305.072497
},
{
"d": "2026-07-20",
"o": 88.58,
"h": 92.1,
"l": 87.865,
"c": 87.99,
"v": 1053678.799703
},
{
"d": "2026-07-21",
"o": 87.99,
"h": 92.2425,
"l": 87.2101,
"c": 91.69,
"v": 1855686.170673
},
{
"d": "2026-07-22",
"o": 90.2,
"h": 92.66,
"l": 89.24,
"c": 90.14,
"v": 792947.135538
}
]
}
Data:
{
"estimates": [
{
"symbol": "CELC",
"date": "2030-12-31",
"revenueLow": 803498249,
"revenueHigh": 2572670369,
"revenueAvg": 1629397875,
"ebitdaLow": 0,
"ebitdaHigh": 0,
"ebitdaAvg": 0,
"ebitLow": 0,
"ebitHigh": 0,
"ebitAvg": 0,
"netIncomeLow": 196755040,
"netIncomeHigh": 1011040176,
"netIncomeAvg": 576886400,
"sgaExpenseLow": 0,
"sgaExpenseHigh": 0,
"sgaExpenseAvg": 0,
"epsAvg": 10.98,
"epsHigh": 19.24334,
"epsLow": 3.74488,
"numAnalystsRevenue": 6,
"numAnalystsEps": 2
},
{
"symbol": "CELC",
"date": "2029-12-31",
"revenueLow": 566900030,
"revenueHigh": 1815121455,
"revenueAvg": 1149605125,
"ebitdaLow": 0,
"ebitdaHigh": 0,
"ebitdaAvg": 0,
"ebitLow": 0,
"ebitHigh": 0,
"ebitAvg": 0,
"netIncomeLow": 133365312,
"netIncomeHigh": 685306892,
"netIncomeAvg": 391027052,
"sgaExpenseLow": 0,
"sgaExpenseHigh": 0,
"sgaExpenseAvg": 0,
"epsAvg": 7.4425,
"epsHigh": 13.04359,
"epsLow": 2.53837,
"numAnalystsRevenue": 3,
"numAnalystsEps": 4
},
{
"symbol": "CELC",
"date": "2028-12-31",
"revenueLow": 715899708,
"revenueHigh": 719729404,
"revenueAvg": 717814556,
"ebitdaLow": 0,
"ebitdaHigh": 0,
"ebitdaAvg": 0,
"ebitLow": 0,
"ebitHigh": 0,
"ebitAvg": 0,
"netIncomeLow": 13585727,
"netIncomeHigh": 338506221,
"netIncomeAvg": 196948290,
"sgaExpenseLow": 0,
"sgaExpenseHigh": 0,
"sgaExpenseAvg": 0,
"epsAvg": 3.27889,
"epsHigh": 6.44286,
"epsLow": 0.25858,
"numAnalystsRevenue": 7,
"numAnalystsEps": 6
},
{
"symbol": "CELC",
"date": "2027-12-31",
"revenueLow": 229329991,
"revenueHigh": 555761190,
"revenueAvg": 392545591,
"ebitdaLow": 0,
"ebitdaHigh": 0,
"ebitdaAvg": 0,
"ebitLow": 0,
"ebitHigh": 0,
"ebitAvg": 0,
"netIncomeLow": -3574945056,
"netIncomeHigh": 2229393780,
"netIncomeAvg": -34947000,
"sgaExpenseLow": 0,
"sgaExpenseHigh": 0,
"sgaExpenseAvg": 0,
"epsAvg": -0.50216,
"epsHigh": 42.43252,
"epsLow": -68.04268,
"numAnalystsRevenue": 7,
"numAnalystsEps": 5
}
],
"price_target": {
"symbol": "CELC",
"targetHigh": 178,
"targetLow": 110,
"targetConsensus": 155.11,
"targetMedian": 157
},
"ratings": {
"symbol": "CELC",
"rating": "D+",
"overallScore": 1,
"discountedCashFlowScore": 1,
"returnOnEquityScore": 1,
"returnOnAssetsScore": 1,
"debtToEquityScore": 1,
"priceToEarningsScore": 1,
"priceToBookScore": 1
},
"grades": [
{
"symbol": "CELC",
"date": "2026-07-15",
"gradingCompany": "Citizens",
"previousGrade": "Market Outperform",
"newGrade": "Market Outperform",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2026-07-15",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2026-06-03",
"gradingCompany": "Craig-Hallum",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2026-06-03",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2026-06-03",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2026-05-18",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2026-05-15",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2026-05-15",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2026-05-04",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2026-05-04",
"gradingCompany": "Citizens",
"previousGrade": "Market Outperform",
"newGrade": "Market Outperform",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2026-05-04",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Neutral",
"newGrade": "Buy",
"action": "upgrade"
},
{
"symbol": "CELC",
"date": "2026-05-04",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2026-03-26",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2026-03-26",
"gradingCompany": "Stifel",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2026-03-17",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2026-03-10",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2025-12-02",
"gradingCompany": "Jefferies",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2025-11-17",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Neutral",
"action": "downgrade"
},
{
"symbol": "CELC",
"date": "2025-11-13",
"gradingCompany": "Stifel",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2025-11-13",
"gradingCompany": "Craig-Hallum",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2025-10-22",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2025-10-20",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2025-10-03",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2025-08-18",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2025-08-15",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2025-07-28",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2025-07-28",
"gradingCompany": "Leerink Partners",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "CELC",
"date": "2025-07-28",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
}
]
}
Data:
[
{
"title": "CELCUITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Celcuity Inc. on Behalf of Celcuity Stockholders and Encourages Investors to Contact the Firm",
"url": "https://www.globenewswire.com/news-release/2026/07/21/3330995/0/en/CELCUITY-ALERT-Bragar-Eagel-Squire-P-C-is-Investigating-Celcuity-Inc-on-Behalf-of-Celcuity-Stockholders-and-Encourages-Investors-to-Contact-the-Firm.html",
"source": "GlobeNewswire Inc.",
"date": "2026-07-21T20:58:00Z",
"summary": "Law firm Bragar Eagel & Squire is investigating Celcuity Inc. for potential securities violations following the company's announcement of FDA approval for breast cancer therapy Revtorpyk with a delayed commercial launch in late Q3 2026. The delayed timeline, contrary to analyst e"
},
{
"title": "Why CELC Stock Declined 15% in a Week Despite a Major FDA Win",
"url": "https://www.zacks.com/stock/news/2957571/why-celc-stock-declined-15-in-a-week-despite-a-major-fda-win?cid=CS-STOCKNEWSAPI-FT-analyst_blog|price_surge_/_plunge-2957571",
"source": "Zacks Investment Research",
"date": "2026-07-21 14:31:07",
"summary": "Celcuity slides 15% despite FDA approval of Revtorpyk as investors focus on a late Q3 2026 launch that delays commercial sales and near-term revenues."
},
{
"title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Celcuity Inc. - CELC",
"url": "https://www.globenewswire.com/news-release/2026/07/21/3330860/1087/en/INVESTOR-ALERT-Pomerantz-Law-Firm-Investigates-Claims-On-Behalf-of-Investors-of-Celcuity-Inc-CELC.html",
"source": "GlobeNewsWire",
"date": "2026-07-21 13:26:00",
"summary": "NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Celcuity Inc. (\u201cCelcuity\u201d or the \u201cCompany\u201d) (NASDAQ: CELC).\u00a0 Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com\u00a0or 646-581-9980, ext.\u00a07980."
},
{
"title": "CELC INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud",
"url": "https://www.globenewswire.com/news-release/2026/07/21/3330168/937/en/CELC-INVESTOR-ALERT-Kirby-McInerney-LLP-Announces-Investigation-Into-Potential-Securities-Fraud.html",
"source": "GlobeNewsWire",
"date": "2026-07-20 20:00:00",
"summary": "NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- The law firm of\u00a0Kirby McInerney LLP is investigating potential claims against Celcuity Inc. (\u201cCelcuity\u201d or the \u201cCompany\u201d) (Nasdaq: CELC). The investigation concerns whether the Company and/or members of its senior management may have vi"
},
{
"title": "Celcuity Enters Commercial Stage as FDA Approves REVTORPYK for Advanced Breast Cancer",
"url": "https://finance.yahoo.com/healthcare/articles/celcuity-enters-commercial-stage-fda-080202179.html",
"source": "Yahoo! Finance",
"date": "2026-07-15T08:02:02Z",
"summary": "* 3 Stocks You'll Wish You Bought Before 2026\n\nCelcuity (NASDAQ:CELC) said the U.S. Food and Drug Administration has granted full approval to gedatolisib, now branded as REVTORPYK, for certain patients with advanced breast cancer, marking the company's transition to a commercial-"
},
{
"title": "Celcuity Inc. (CELC) Discusses FDA Approval of REVTORPYK for Advanced HR+/HER2- Breast Cancer and Commercial Launch Plans Transcript",
"url": "https://seekingalpha.com/article/4922420-celcuity-inc-celc-discusses-fda-approval-of-revtorpyk-for-advanced-hr-her2-breast-cancer-and",
"source": "Seeking Alpha",
"date": "2026-07-15 16:17:57",
"summary": "Celcuity Inc. (CELC) Discusses FDA Approval of REVTORPYK for Advanced HR+/HER2- Breast Cancer and Commercial Launch Plans Transcript"
},
{
"title": "Celcuity: 'Buy' REVTORPYK FDA Approval First And sNDA Label Expansion Q3 2026",
"url": "https://seekingalpha.com/article/4922370-celcuity-buy-revtorpyk-fda-approval-first-and-snda-label-expansion-q3-2026",
"source": "Seeking Alpha",
"date": "2026-07-15 13:45:24",
"summary": "Celcuity Inc. secured FDA approval for REVTORPYK, the first pan-PI3K, mTORC1/2 inhibitor for 2nd-line PIK3CA wild-type HR+/HER2- advanced breast cancer. I downgrade CELC from Strong Buy to Buy due to phase 3 mutant cohort data underperforming prior results and rising competitive "
},
{
"title": "Celcuity shares fall as delayed breast cancer drug launch eclipses first US FDA approval",
"url": "https://www.reuters.com/legal/litigation/celcuity-shares-fall-delayed-breast-cancer-drug-launch-eclipses-first-us-fda-2026-07-15/",
"source": "Reuters",
"date": "2026-07-15 08:43:57",
"summary": "Shares of Celcuity fell about 8% in premarket trading on Wednesday, as the delayed commercial launch of its newly \u200bapproved breast cancer drug and treatment-tolerability concerns overshadowed the \u200ccompany's first U.S. approval."
},
{
"title": "Celcuity Announces FDA Approval of REVTORPYK\u2122 (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer",
"url": "https://www.globenewswire.com/news-release/2026/07/14/3327323/0/en/Celcuity-Announces-FDA-Approval-of-REVTORPYK-gedatolisib-for-the-Treatment-of-HR-HER2-PIK3CA-Wild-Type-Locally-Advanced-or-Metastatic-Breast-Cancer.html",
"source": "GlobeNewswire Inc.",
"date": "2026-07-14T20:53:00Z",
"summary": "Celcuity announced FDA approval of REVTORPYK (gedatolisib), the first pan-PI3K and mTORC1/2 inhibitor, for treating HR+/HER2- locally advanced or metastatic breast cancer without PIK3CA mutations. In the Phase 3 VIKTORIA-1 trial, the drug reduced disease progression or death risk"
},
{
"title": "Celcuity Inc. (CELC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript",
"url": "https://seekingalpha.com/article/4913744-celcuity-inc-celc-presents-at-goldman-sachs-47th-annual-global-healthcare-conference-2026",
"source": "Seeking Alpha",
"date": "2026-06-10 15:32:13",
"summary": "Celcuity Inc. (CELC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript"
},
{
"title": "Celcuity Inc. Announces Pricing of Upsized Public Offering of 0.250% Convertible Senior Notes Due 2032",
"url": "https://www.globenewswire.com/news-release/2026/06/04/3306482/0/en/Celcuity-Inc-Announces-Pricing-of-Upsized-Public-Offering-of-0-250-Convertible-Senior-Notes-Due-2032.html",
"source": "GlobeNewswire Inc.",
"date": "2026-06-04T02:13:00Z",
"summary": "Celcuity Inc., a clinical-stage biotechnology company, announced the pricing of an upsized $500 million convertible senior notes offering due 2032, increased from the previously announced $400 million. The company plans to use net proceeds of approximately $484.3 million to repay"
},
{
"title": "Celcuity: Selloff On Yesterday's Data Unwarranted - Buy Rating Upheld",
"url": "https://seekingalpha.com/article/4911391-celcuity-selloff-on-yesterdays-data-unwarranted-buy-rating-upheld",
"source": "Seeking Alpha",
"date": "2026-06-03 09:33:26",
"summary": "Celcuity (CELC) shares dropped over 25% despite Phase 3 VIKTORIA-1 data confirming gedatolisib's best-in-class efficacy in advanced breast cancer. Gedatolisib demonstrated superior progression-free survival and objective response rates versus current standards, supporting blockbu"
},
{
"title": "Why Celcuity Stock Popped on Monday",
"url": "https://www.fool.com/investing/2026/04/27/why-celcuity-stock-popped-on-monday/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-04-27T22:18:13Z",
"summary": "Celcuity stock rose nearly 4% after analyst Silvan Turkcan from Citizens initiated coverage with a 'market outperform' rating and $150 price target. The bullish outlook centers on gedatolisib, the company's investigational breast cancer drug, which is less than two months away fr"
},
{
"title": "Micron, Oracle among market cap stock movers on Wednesday By Investing.com",
"url": "https://www.investing.com/news/stock-market-news/micron-oracle-among-market-cap-stock-movers-on-wednesday-93CH-4793765",
"source": "Investing.com",
"date": "2026-04-20T18:08:21Z",
"summary": "Wednesday's market has seen significant movements in various stocks, influenced by news and other factors. Today, stocks like PayPal Holdings and Aehr Test Systems are rallying, while others like Micron Tech and Applied Opt are experiencing declines. Below are highlights of some "
},
{
"title": "Citizens raises Celcuity stock price target to $177 on drug approval By Investing.com",
"url": "https://www.investing.com/news/analyst-ratings/citizens-raises-celcuity-stock-price-target-to-177-on-drug-approval-93CH-4792497",
"source": "Investing.com",
"date": "2026-04-20T18:08:21Z",
"summary": "Investing.com - Citizens raised its price target on Celcuity Inc (NASDAQ:CELC) shares to $177 from $160 while maintaining a Market Outperform rating following the company's drug approval. The stock currently trades at $111.05 with analysts maintaining a strong buy consensus, thou"
},
{
"title": "Why is Celcuity stock surging today? By Investing.com",
"url": "https://www.investing.com/news/stock-market-news/why-is-celcuity-stock-surging-today-93CH-4791539",
"source": "Investing.com",
"date": "2026-04-20T18:08:21Z",
"summary": "Investing.com -- Celcuity stock surged 6.6% in afternoon trading as investors rushed to build positions ahead of what could be the company's most consequential moment to date: an FDA approval decision on gedatolisib, its lead oncology drug candidate, scheduled for July 17, 2026 -"
},
{
"title": "Why Celcuity Stock Popped Today",
"url": "https://www.fool.com/investing/2026/03/26/why-celcuity-stock-popped-today/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-03-27T00:05:32Z",
"summary": "Celcuity stock rose over 4% after releasing its 2025 financial results, beating analyst expectations with a narrower-than-expected net loss of $0.73 per share versus the projected $1.05. The clinical-stage biotech, which has no revenue, significantly improved its cash position to"
},
{
"title": "Inside One Fund's $170 Million Bet on a Biotech Stock Up 1,040% in a Year Amid FDA Review for Breast Cancer Drug",
"url": "https://www.fool.com/coverage/filings/2026/03/13/inside-one-fund-s-usd170-million-bet-on-a-biotech-stock-up-1-040-in-a-year-amid-fda-review-for-breast-cancer-drug/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-03-13T14:28:06Z",
"summary": "Deerfield Management Company increased its stake in Celcuity by 980,470 shares (worth $80.6 million) in Q4, bringing its total position to $170.95 million. Celcuity's stock has surged 1,040% over the past year as the FDA accepted its new drug application for gedatolisib in breast"
},
{
"title": "Celcuity Announces Publication of Results from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Study of Gedatolisib Regimens in HR+/HER2- Advanced Breast Cancer in Journal of Clinical Oncology",
"url": "https://www.globenewswire.com/news-release/2026/03/09/3252366/0/en/Celcuity-Announces-Publication-of-Results-from-PIK3CA-Wild-Type-Cohort-of-Phase-3-VIKTORIA-1-Study-of-Gedatolisib-Regimens-in-HR-HER2-Advanced-Breast-Cancer-in-Journal-of-Clinical-.html",
"source": "GlobeNewswire Inc.",
"date": "2026-03-09T21:42:00Z",
"summary": "Celcuity announced publication of Phase 3 VIKTORIA-1 trial results showing gedatolisib combined with palbociclib and fulvestrant reduced disease progression or death risk by 76% in HR+/HER2- advanced breast cancer patients with PIK3CA wild-type mutations. The FDA has granted Prio"
},
{
"title": "Celcuity Stock Soars 700% in a Year as One Investor's $17 Million Buy Helps Create Top Two Position",
"url": "https://www.fool.com/coverage/filings/2026/02/22/celcuity-stock-soars-700-in-a-year-as-one-investor-s-usd17-million-buy-helps-create-top-two-position/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-02-22T19:05:11Z",
"summary": "Perceptive Advisors purchased 203,881 shares of Celcuity (CELC) in Q4 2025 for approximately $16.76 million, bringing its stake to 5.62% of AUM and making it the fund's second-largest holding. The stock has surged 700% over the past year, driven by anticipation of FDA approval fo"
},
{
"title": "Soleus Adds a Significant Number of Celcuity Shares",
"url": "https://www.fool.com/coverage/filings/2026/02/13/soleus-adds-significant-number-celcuity-shares/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-02-13T12:34:09Z",
"summary": "Soleus Capital Management increased its stake in Celcuity by 629,398 shares, bringing its total holdings to over 1.8 million shares valued at $180.36 million. This purchase elevated Celcuity to Soleus's third-largest holding, representing 6.7% of the fund's AUM. The move signals "
},
{
"title": "Director Sells 20,000 Celcuity Shares for $2.4 Million Following 933% Share Price Jump",
"url": "https://www.fool.com/coverage/filings/2026/02/06/director-sells-20-000-celcuity-shares-for-usd2-4-million-following-933-share-price-jump/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-02-06T21:05:40Z",
"summary": "Celcuity director David Dalvey sold 20,000 shares indirectly for $2.4 million on January 27, 2026, representing 18.18% of his holdings. The sale occurred via a Rule 10b5-1 trading plan through Brightstone Venture Capital Fund. Despite the insider sale, Celcuity stock has surged 9"
},
{
"title": "3 Stocks You\u2019ll Wish You Bought Before 2026",
"url": "https://www.investing.com/analysis/3-stocks-youll-wish-you-bought-before-2026-200671271",
"source": "Investing.com",
"date": "2025-12-04T09:47:00Z",
"summary": "The article highlights three small-cap stocks that have shown impressive gains in 2025, including a biotech company, a fintech platform, and an online consignment store, each with unique market potential and growth trajectories."
},
{
"title": "This Fund Bought $38 Million of Celcuity as Stock Surges on Investigational Cancer Drug Results",
"url": "https://www.fool.com/coverage/filings/2025/11/27/this-fund-bought-usd38-million-of-celcuity-as-stock-surges-on-investigational-cancer-drug-results/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2025-11-27T22:22:01Z",
"summary": "Apis Capital Advisors invested $38.3 million in Celcuity, acquiring 776,000 shares during Q3 2025, making it their largest holding. Celcuity, a clinical-stage biotech firm, has seen its stock surge 669% in a year following positive phase 3 results for its cancer drug gedatolisib."
},
{
"title": "Detailed Results from\u00a0PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Trial Presented at 2025 ESMO Congress Demonstrate Potential for Gedatolisib Regimens to be Practice Changing for Patients with HR+/HER2- Advanced Breast Cancer",
"url": "https://www.globenewswire.com/news-release/2025/10/18/3168946/0/en/Detailed-Results-from-PIK3CA-Wild-Type-Cohort-of-Phase-3-VIKTORIA-1-Trial-Presented-at-2025-ESMO-Congress-Demonstrate-Potential-for-Gedatolisib-Regimens-to-be-Practice-Changing-for.html",
"source": "GlobeNewswire Inc.",
"date": "2025-10-18T08:30:00Z",
"summary": "Celcuity announced promising Phase 3 trial results for gedatolisib, a multi-target PAM inhibitor for advanced breast cancer, demonstrating significant improvements in progression-free survival and response rates compared to standard treatment."
}
]
Data:
[
{
"symbol": "CELC",
"date": "2026-08-13",
"epsActual": null,
"epsEstimated": -1.08,
"revenueActual": null,
"revenueEstimated": 3918050,
"lastUpdated": "2026-07-23"
},
{
"symbol": "CELC",
"date": "2026-05-14",
"epsActual": -0.97,
"epsEstimated": -1.04,
"revenueActual": null,
"revenueEstimated": 2938537,
"lastUpdated": "2026-07-23"
},
{
"symbol": "CELC",
"date": "2026-03-25",
"epsActual": -0.97,
"epsEstimated": -1.06,
"revenueActual": null,
"revenueEstimated": 1275000,
"lastUpdated": "2026-06-25"
},
{
"symbol": "CELC",
"date": "2025-11-12",
"epsActual": -0.92,
"epsEstimated": -1.02,
"revenueActual": null,
"revenueEstimated": null,
"lastUpdated": "2026-02-11"
},
{
"symbol": "CELC",
"date": "2025-08-14",
"epsActual": -1.04,
"epsEstimated": -0.9,
"revenueActual": null,
"revenueEstimated": null,
"lastUpdated": "2025-11-14"
}
]
Data:
{
"borrow": [
{
"date": "2026-07-21",
"fee_pct": 0.4244,
"available": 300000,
"rebate_pct": 3.1956,
"high_fee": 0.5204,
"low_fee": 0.4237,
"utilization_signal": "Medium"
},
{
"date": "2026-07-20",
"fee_pct": 0.5188,
"available": 250000,
"rebate_pct": 3.1012,
"high_fee": 0.5188,
"low_fee": 0.4968,
"utilization_signal": "Medium"
},
{
"date": "2026-07-17",
"fee_pct": 0.5067,
"available": 150000,
"rebate_pct": 3.1133,
"high_fee": 0.5067,
"low_fee": 0.4695,
"utilization_signal": "Medium"
},
{
"date": "2026-07-16",
"fee_pct": 0.4695,
"available": 100000,
"rebate_pct": 3.1605,
"high_fee": 0.4716,
"low_fee": 0.4683,
"utilization_signal": "Medium"
},
{
"date": "2026-07-15",
"fee_pct": 0.4711,
"available": 800000,
"rebate_pct": 3.1589,
"high_fee": 0.519,
"low_fee": 0.4711,
"utilization_signal": "Medium"
}
],
"short_interest": [
{
"symbol": "CELC",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "CELC",
"periods": [
{
"file_period": "202603a",
"settlement_date": "20260311",
"quantity_fails": 1226,
"price": 117.1
},
{
"file_period": "202603b",
"settlement_date": "20260326",
"quantity_fails": 3004,
"price": 110.22
},
{
"file_period": "202604a",
"settlement_date": "20260408",
"quantity_fails": 1488,
"price": 115.56
},
{
"file_period": "202604b",
"settlement_date": "20260420",
"quantity_fails": 234,
"price": 122.46
},
{
"file_period": "202606a",
"settlement_date": "20260612",
"quantity_fails": 1191,
"price": 89.49
},
{
"file_period": "202606b",
"settlement_date": "20260630",
"quantity_fails": 22193,
"price": 102.52
}
],
"trend": "rising",
"trend_description": "FTD quantity increasing \u2014 settlement pressure building, potential squeeze precursor"
}
}
Data:
{
"insider": [
{
"symbol": "CELC",
"filingDate": "2026-07-16",
"transactionDate": "2026-07-14",
"reportingCik": "0001263508",
"companyCik": "0001603454",
"transactionType": "S-Sale",
"securitiesOwned": 4372852,
"reportingName": "BAKER BROS. ADVISORS LP",
"typeOfOwner": "other: Former 10% owner",
"acquisitionOrDisposition": "D",
"directOrIndirect": "I",
"formType": "4",
"securitiesTransacted": 2838632,
"price": 102.5,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000119312526306299/0001193125-26-306299-index.htm"
},
{
"symbol": "CELC",
"filingDate": "2026-07-16",
"transactionDate": "2026-07-14",
"reportingCik": "0001263508",
"companyCik": "0001603454",
"transactionType": "S-Sale",
"securitiesOwned": 442940,
"reportingName": "BAKER BROS. ADVISORS LP",
"typeOfOwner": "other: Former 10% owner",
"acquisitionOrDisposition": "D",
"directOrIndirect": "I",
"formType": "4",
"securitiesTransacted": 261368,
"price": 102.5,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000119312526306299/0001193125-26-306299-index.htm"
},
{
"symbol": "CELC",
"filingDate": "2026-06-12",
"transactionDate": "2026-06-10",
"reportingCik": "0001829248",
"companyCik": "0001603454",
"transactionType": "G-Gift",
"securitiesOwned": 14048,
"reportingName": "Murphy Polly A.",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "I",
"formType": "4",
"securitiesTransacted": 14048,
"price": 10.69,
"securityName": "Stock Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000182924826000004/0001829248-26-000004-index.htm"
},
{
"symbol": "CELC",
"filingDate": "2026-06-12",
"transactionDate": "2026-06-10",
"reportingCik": "0001829248",
"companyCik": "0001603454",
"transactionType": "G-Gift",
"securitiesOwned": 0,
"reportingName": "Murphy Polly A.",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 14048,
"price": 10.69,
"securityName": "Stock Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000182924826000004/0001829248-26-000004-index.htm"
},
{
"symbol": "CELC",
"filingDate": "2026-06-12",
"transactionDate": "2026-06-10",
"reportingCik": "0001688319",
"companyCik": "0001603454",
"transactionType": "G-Gift",
"securitiesOwned": 12503,
"reportingName": "Buller Richard E",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "I",
"formType": "4",
"securitiesTransacted": 12503,
"price": 10.69,
"securityName": "Stock Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000168831926000010/0001688319-26-000010-index.htm"
},
{
"symbol": "CELC",
"filingDate": "2026-06-12",
"transactionDate": "2026-06-10",
"reportingCik": "0001688319",
"companyCik": "0001603454",
"transactionType": "G-Gift",
"securitiesOwned": 0,
"reportingName": "Buller Richard E",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 12503,
"price": 10.69,
"securityName": "Stock Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000168831926000010/0001688319-26-000010-index.htm"
},
{
"symbol": "CELC",
"filingDate": "2026-06-09",
"transactionDate": "2026-06-05",
"reportingCik": "0001829248",
"companyCik": "0001603454",
"transactionType": "A-Award",
"securitiesOwned": 6530,
"reportingName": "Murphy Polly A.",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 1530,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000182924826000002/0001829248-26-000002-index.htm"
},
{
"symbol": "CELC",
"filingDate": "2026-06-09",
"transactionDate": "2026-06-05",
"reportingCik": "0001296457",
"companyCik": "0001603454",
"transactionType": "A-Award",
"securitiesOwned": 1530,
"reportingName": "Dalvey David",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 1530,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1603454/000129645726000008/0001296457-26-000008-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
{
"symbol": "CELC",
"senateID": "M001203",
"disclosureDate": "2021-08-26",
"transactionDate": "2020-06-22",
"firstName": "Tom",
"lastName": "Malinowski",
"office": "Tom Malinowski",
"district": "NJ07",
"owner": "",
"assetDescription": "Celcuity Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2021/20019374.pdf"
},
{
"symbol": "CELC",
"senateID": "M001203",
"disclosureDate": "2021-08-26",
"transactionDate": "2020-06-23",
"firstName": "Tom",
"lastName": "Malinowski",
"office": "Tom Malinowski",
"district": "NJ07",
"owner": "",
"assetDescription": "Celcuity Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2021/20019374.pdf"
},
{
"symbol": "CELC",
"senateID": "M001203",
"disclosureDate": "2021-06-23",
"transactionDate": "2021-05-26",
"firstName": "Tom",
"lastName": "Malinowski",
"office": "Tom Malinowski",
"district": "NJ07",
"owner": "",
"assetDescription": "Celcuity Inc",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2021/20018967.pdf"
}
],
"dark_pool": [
{
"ticker": "CELC",
"executed_at": "2026-07-22T20:00:01.121000Z",
"size": 7439.0,
"price": 90.14,
"premium": 670551.46,
"volume": 7439.0,
"trade_code": "6"
},
{
"ticker": "CELC",
"executed_at": "2026-07-22T20:00:01.121000Z",
"size": 3648.0,
"price": 90.14,
"premium": 328830.72000000003,
"volume": 3648.0,
"trade_code": "6"
},
{
"ticker": "CELC",
"executed_at": "2026-07-22T20:00:01.122000Z",
"size": 3252.0,
"price": 90.14,
"premium": 293135.28,
"volume": 3252.0,
"trade_code": "6"
},
{
"ticker": "CELC",
"executed_at": "2026-07-22T20:00:01.121000Z",
"size": 2835.0,
"price": 90.14,
"premium": 255546.9,
"volume": 2835.0,
"trade_code": "6"
},
{
"ticker": "CELC",
"executed_at": "2026-07-22T20:00:07.722000Z",
"size": 2744.0,
"price": 90.14,
"premium": 247344.16,
"volume": 2744.0,
"trade_code": " "
},
{
"ticker": "CELC",
"executed_at": "2026-07-22T20:00:07.724000Z",
"size": 2407.0,
"price": 90.14,
"premium": 216966.98,
"volume": 2407.0,
"trade_code": " "
},
{
"ticker": "CELC",
"executed_at": "2026-07-22T20:00:01.121000Z",
"size": 2206.0,
"price": 90.14,
"premium": 198848.84,
"volume": 2206.0,
"trade_code": "6"
},
{
"ticker": "CELC",
"executed_at": "2026-07-22T20:00:45.435000Z",
"size": 1912.0,
"price": 90.14,
"premium": 172347.68,
"volume": 1912.0,
"trade_code": " "
}
],
"ats": {
"symbol": "CELC",
"date": "20260722",
"ats_volume": 0,
"total_volume": 288180,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260722",
"ats_ratio": 0.0
},
{
"date": "20260721",
"ats_ratio": 0.0
},
{
"date": "20260720",
"ats_ratio": 0.0
},
{
"date": "20260717",
"ats_ratio": 0.0
},
{
"date": "20260716",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "CELC",
"days": [
{
"date": "2026-07-22",
"close": 90.14,
"vwap": 90.78,
"volume": 792947,
"vwap_discount_pct": 0.71
},
{
"date": "2026-07-21",
"close": 91.69,
"vwap": 90.85,
"volume": 1855686,
"vwap_discount_pct": -0.92
},
{
"date": "2026-07-20",
"close": 87.99,
"vwap": 89.35,
"volume": 1053678,
"vwap_discount_pct": 1.54
},
{
"date": "2026-07-17",
"close": 88.38,
"vwap": 88.74,
"volume": 1310305,
"vwap_discount_pct": 0.41
},
{
"date": "2026-07-16",
"close": 88.29,
"vwap": 87.73,
"volume": 3416798,
"vwap_discount_pct": -0.63
}
],
"avg_vwap_discount_pct": 0.22,
"signal": "Accumulation"
},
"options_flow": [
{
"premium": "17700.00",
"nbbo_bid": "15.30",
"expiry": "2026-11-20",
"underlying_symbol": "CELC",
"size": 10,
"option_chain_id": "CELC261120C00090000",
"executed_at": "2026-07-22T15:24:59.605719Z",
"open_interest": 10,
"price": "17.70",
"nbbo_ask": "18.80",
"underlying_price": "92.52",
"implied_volatility": "0.763696185474855",
"sector": "Healthcare",
"strike": "90",
"delta": "0.622846729738152",
"option_type": "call",
"volume": 10
}
],
"net_premium": {
"ticker": "CELC",
"net_call_premium": "9282.00",
"net_put_premium": "-57723.00",
"call_premium": "54742.00",
"put_premium": "74971.00",
"bullish_premium": "95044.00",
"bearish_premium": "28039.00",
"put_call_ratio": "1.4150943396226415",
"iv_rank": "5.1175",
"implied_move_perc": "0.122000",
"gex_ratio": "1.21933153488162432287",
"gex_net_change": "827.7333",
"gex_call_delta": "484114.2693",
"gex_put_delta": "-682106.0543",
"gex_date": "2026-07-22"
},
"hot_chains": [
{
"underlying_symbol": "CELC",
"expires": "2026-09-18",
"open_interest": 55,
"option_type": "put",
"delta": -0.162218033266883,
"ask_volume": 3,
"last_price": "2.70",
"implied_volatility": "0.785655055928344",
"gamma": 0.00892223995557711,
"avg_price": "2.6006930693069306930693069309",
"bid_volume": 199,
"nbbo_ask": "3.60",
"strike": "70",
"option_symbol": "CELC260918P00070000",
"total_premium": "52534.00",
"iv": 0.76492626439172,
"volume": 202,
"nbbo_bid": "1.65"
},
{
"underlying_symbol": "CELC",
"expires": "2026-09-18",
"open_interest": 60,
"option_type": "call",
"delta": 0.140441498859177,
"ask_volume": 9,
"last_price": "1.55",
"implied_volatility": "0.70393160176923",
"gamma": 0.00830843567946379,
"avg_price": "1.6055769230769230769230769231",
"bid_volume": 30,
"nbbo_ask": "2.45",
"strike": "130",
"option_symbol": "CELC260918C00130000",
"total_premium": "8349.00",
"iv": 0.746308074714541,
"volume": 52,
"nbbo_bid": "0.65"
},
{
"underlying_symbol": "CELC",
"expires": "2026-10-16",
"open_interest": 4,
"option_type": "call",
"delta": 0.087066006432359,
"ask_volume": 23,
"last_price": "1.15",
"implied_volatility": "0.6760590153734",
"gamma": 0.00527077529286548,
"avg_price": "1.1732142857142857142857142856",
"bid_volume": 2,
"nbbo_ask": "1.35",
"strike": "150",
"option_symbol": "CELC261016C00150000",
"total_premium": "3285.00",
"iv": 0.686212157928076,
"volume": 28,
"nbbo_bid": "0.75"
},
{
"underlying_symbol": "CELC",
"expires": "2026-08-21",
"open_interest": 332,
"option_type": "call",
"delta": 0.12485204122672,
"ask_volume": 4,
"last_price": "1.00",
"implied_volatility": "0.740734085825048",
"gamma": 0.0101068149004451,
"avg_price": "1.0480769230769230769230769231",
"bid_volume": 12,
"nbbo_ask": "1.80",
"strike": "120",
"option_symbol": "CELC260821C00120000",
"total_premium": "2725.00",
"iv": 0.78661594151157,
"volume": 26,
"nbbo_bid": "0.25"
},
{
"underlying_symbol": "CELC",
"expires": "2026-08-21",
"open_interest": 320,
"option_type": "call",
"delta": 0.213596230474481,
"ask_volume": 3,
"last_price": "2.05",
"implied_volatility": "0.733011807838957",
"gamma": 0.0147195245462594,
"avg_price": "2.2952631578947368421052631579",
"bid_volume": 16,
"nbbo_ask": "2.65",
"strike": "110",
"option_symbol": "CELC260821C00110000",
"total_premium": "4361.00",
"iv": 0.764355100310461,
"volume": 19,
"nbbo_bid": "1.70"
},
{
"underlying_symbol": "CELC",
"expires": "2026-08-21",
"open_interest": 140,
"option_type": "put",
"delta": -0.0967617300652028,
"ask_volume": 5,
"last_price": "1.20",
"implied_volatility": "0.830317440594012",
"gamma": 0.00892404383610388,
"avg_price": "1.3000",
"bid_volume": 5,
"nbbo_ask": "1.50",
"strike": "70",
"option_symbol": "CELC260821P00070000",
"total_premium": "1300.00",
"iv": 0.742027339054475,
"volume": 10,
"nbbo_bid": "0.70"
},
{
"underlying_symbol": "CELC",
"expires": "2026-11-20",
"open_interest": 10,
"option_type": "call",
"delta": 0.592222460793362,
"ask_volume": 10,
"last_price": "17.70",
"implied_volatility": "0.763696185474855",
"gamma": 0.00945921378742681,
"avg_price": "17.70",
"bid_volume": 0,
"nbbo_ask": "17.80",
"strike": "90",
"option_symbol": "CELC261120C00090000",
"total_premium": "17700.00",
"iv": 0.78980007802417,
"volume": 10,
"nbbo_bid": "14.90"
},
{
"underlying_symbol": "CELC",
"expires": "2026-08-21",
"open_interest": 786,
"option_type": "call",
"delta": 0.549909637064248,
"ask_volume": 0,
"last_price": "8.48",
"implied_volatility": "0.766945978120623",
"gamma": 0.0192846092153242,
"avg_price": "8.48",
"bid_volume": 4,
"nbbo_ask": "9.90",
"strike": "90",
"option_symbol": "CELC260821C00090000",
"total_premium": "3392.00",
"iv": 0.793342699320823,
"volume": 4,
"nbbo_bid": "6.50"
}
],
"oi_changes": {
"net_call_oi_change": 6,
"net_put_oi_change": 0,
"top": [
{
"strike": "90",
"oi_change": 6,
"type": "call"
},
{
"strike": "130",
"oi_change": 0,
"type": "put"
},
{
"strike": "90",
"oi_change": 0,
"type": "put"
},
{
"strike": "100",
"oi_change": 0,
"type": "put"
},
{
"strike": "105",
"oi_change": 0,
"type": "put"
}
]
}
}
Data:
{
"vix": 18.77,
"sp500": 7443.28,
"fed_funds": 3.64,
"yield_curve_10y2y": 0.39,
"hy_spread": 2.73,
"treasury": {
"date": "2026-07-22",
"month1": 3.76,
"month2": 3.82,
"month3": 3.89,
"month6": 4.05,
"year1": 4.11,
"year2": 4.31,
"year3": 4.34,
"year5": 4.41,
"year7": 4.53,
"year10": 4.67,
"year20": 5.17,
"year30": 5.15
},
"events": []
}
Data:
{
"days": 45,
"patterns": [
{
"name": "ORB Breakout",
"count": 45,
"pct": 100
},
{
"name": "VWAP Touch",
"count": 45,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 45,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 45,
"pct": 100
},
{
"name": "Woodie Pivot Touch",
"count": 44,
"pct": 98
},
{
"name": "PDH/PDL Touch",
"count": 40,
"pct": 89
},
{
"name": "Open Retracement",
"count": 39,
"pct": 87
},
{
"name": "Gap Fill",
"count": 35,
"pct": 78
},
{
"name": "Darvas Box",
"count": 22,
"pct": 49
},
{
"name": "High Vol Open",
"count": 12,
"pct": 27
},
{
"name": "Power Hour",
"count": 11,
"pct": 24
}
]
}